Task: Answer the multiple choice question.
Query: Which compound exhibits a 16.115\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) COC(CNC(=O)c1ccc2c(c1)ncn2C1CCCCCC1)OC
b.) Cn1c(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)nc(Br)c1Br
c.) NC(=O)CSc1oc(-c2ccco2)nc1S(=O)(=O)c1ccc(Cl)cc1
d.) Cc1c(C(=O)NCCSCc2cccc(C(F)(F)F)c2)cnn1-c1ccc(F)cc1
Answer: b. Cn1c(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)nc(Br)c1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)nc(Br)c1Br
Cn1c(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)nc(Br)c1Br
[4-(4,5-dibromo-1-methylimidazol-2-yl)sulfonylphenyl]-oxido-oxoazanium